Dementia research news

The latest in dementia treatment and diagnosis

Read our selection of news covering the biggest advancements drug and treatments development, as well as news relating to improving dementia diagnosis and care.

Researching new drugs for Alzheimer’s disease

Research never stops. There are a number of promising breakthrough drugs that have finished or are coming to the end of their clinical trial.

Find out more

Blood biomarkers for diagnosis

Blood-based biomarkers could be the cost-effective, accurate and non-invasive diagnostic tool that is needed to revolutionise diagnosis.

Learn more

Our response to claims anti-amyloid drugs are ineffective

Alzheimer's Society and leading experts respond to Cochrane review of ‘Amyloid-beta-targeting monoclonal antibodies for people with mild cognitive impairment or mild dementia due to Alzheimer’s disease’.

Read our response

The next generation of antibody treatments

The blood-brain barrier acts as a gatekeeper restricting what can and cannot reach the brain. Researchers are designing treatments to cross the blood-brain barrier more effectively.

Turning existing drugs into new dementia treatments

Researchers are exploring whether existing, safe medicines could be adapted and used to treat dementia.

Looking back at an exciting year for research

We described 2024 as the biggest year for dementia research yet - and now, 2025 has proved to be just as impactful.

Dementia research updates

Read the latest about dementia research conducted and funded by Alzheimer's Society, as well as the most recent news from the wider dementia research community.

Research highlight

Dementia research news

The latest in dementia treatment and diagnosis

Researching new drugs for Alzheimer’s disease

Blood biomarkers for diagnosis

Our response to claims anti-amyloid drugs are ineffective

The next generation of antibody treatments

Turning existing drugs into new dementia treatments

Looking back at an exciting year for research

Dementia research updates

Investing in the future of dementia research with over £5m awarded to early career researchers

What is Neprilysin and how could it help in treating Alzheimer’s disease?

Honouring Carol Jennings and her legacy through groundbreaking dementia research

Supporting researchers from Black heritage – our new partnership with the Royal Society

Professor Nathan Davies: My journey into dementia care research

Useful links

The latest in dementia treatment and diagnosis

Hear from the experts

Dementia research updates

Useful links